CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by García-Pérez, M. A.
Right arrow Articles by Arnaiz-Villena, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by García-Pérez, M. A.
Right arrow Articles by Arnaiz-Villena, A.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2001, p. 757-761, Vol. 8, No. 4
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.4.757-761.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Role of Nijmegen Breakage Syndrome Protein in Specific T-Lymphocyte Activation Pathways

Miguel Angel García-Pérez,1 Luis M. Allende,1 Alfredo Corell,1 Estela Paz-Artal,1 Pilar Varela,1 Alberto López-Goyanes,1 Francisco García-Martin,2 Rosario Vázquez,2 Amalia Sotoca,1 and Antonio Arnaiz-Villena1,*

Department of Immunology, Hospital Universitario 12 de Octubre, Universidad Complutense, Carretera de Andalucia, 28041 Madrid,1 and Department of Pediatrics, Hospital Regional Carlos Haya, Málaga,2 Spain

Received 23 October 2000/Returned for modification 13 December 2000/Accepted 22 March 2001

Nijmegen breakage syndrome (NBS) is a genetic disorder characterized by immunodeficiency, microcephaly, and "bird-like" facies. NBS shares some clinical features with ataxia telangiectasia (AT), including increased sensitivity to ionizing radiation, increased spontaneous and induced chromosome fragility, and strong predisposition to lymphoid cancers. The mutated gene that results in NBS codes for a novel double-stranded DNA break repair protein, named nibrin. In the present work, a Spanish NBS patient was extensively characterized at the immunological and the molecular DNA levels. He showed low CD3+-cell numbers and an abnormal low CD4+ naive cell/CD4+ memory cell ratio, previously described in AT patients and also described in the present report in the NBS patient. The proliferative response of peripheral blood lymphocytes in vitro to mitogens is deficient in NBS patients, but the possible link among NBS mutations and the abnormal immune response is still unknown.


* Corresponding author. Mailing address: Department of Immunology, Hospital 12 de Octubre, Carretera de Andalucia, 28041-Madrid, Spain. Phone: 34-91-3908315. Fax: 34-91-3908399. E-mail: aarnaiz{at}eucmax.sim.ucm.es.


Clinical and Diagnostic Laboratory Immunology, July 2001, p. 757-761, Vol. 8, No. 4
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.4.757-761.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.